Literature DB >> 25217197

An update on the impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk of bronchopulmonary dysplasia.

Lex W Doyle1, Henry L Halliday2, Richard A Ehrenkranz3, Peter G Davis4, John C Sinclair5.   

Abstract

Infants at higher risk of bronchopulmonary dysplasia had increased rates of survival free of cerebral palsy after postnatal corticosteroid treatment in a previous metaregression of data from 14 randomized controlled trials. The relationship persists and is stronger in an updated analysis with data from 20 randomized controlled trials.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25217197     DOI： 10.1016/j.jpeds.2014.07.049

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  34 in total

Review 1.  The Challenge of Risk Stratification of Infants Born Preterm in the Setting of Competing and Disparate Healthcare Outcomes.

Authors:  Halana V Whitehead; Christopher C McPherson; Zachary A Vesoulis; Barbara A Cohlan; Rakesh Rao; Barbara B Warner; F Sessions Cole
Journal:  J Pediatr       Date:  2020-08       Impact factor: 4.406

Review 2.  Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.

Authors:  Wes Onland; Anne Pmc De Jaegere; Martin Offringa; Anton van Kaam
Journal:  Cochrane Database Syst Rev       Date:  2017-01-31

3.  Precocious glucocorticoid exposure reduces skeletal muscle satellite cells in the fetal rat.

Authors:  Ganga Gokulakrishnan; Xiaoyan Chang; Ryan Fleischmann; Marta L Fiorotto
Journal:  J Endocrinol       Date:  2017-01-17       Impact factor: 4.286

Review 4.  Optimizing respiratory management in preterm infants: a review of adjuvant pharmacotherapies.

Authors:  Jenny K Koo; Robin Steinhorn; Anup C Katheria
Journal:  J Perinatol       Date:  2021-07-09       Impact factor: 2.521

Review 5.  Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia in preterm infants.

Authors:  Brigitte Lemyre; Michael Dunn; Bernard Thebaud
Journal:  Paediatr Child Health       Date:  2020-08-01       Impact factor: 2.253

6.  Development of severe bronchopulmonary dysplasia is associated with alterations in fecal volatile organic compounds.

Authors:  Daniel J C Berkhout; Hendrik J Niemarkt; Marc A Benninga; Andries E Budding; Anton H van Kaam; Boris W Kramer; Charlene M Pantophlet; Mirjam M van Weissenbruch; Nanne K H de Boer; Tim G J de Meij
Journal:  Pediatr Res       Date:  2017-11-22       Impact factor: 3.756

7.  Respiratory Support for Very Low Birth Weight Infants Receiving Dexamethasone.

Authors:  Yamini V Virkud; Christoph P Hornik; Daniel K Benjamin; Matthew M Laughon; Reese H Clark; Rachel G Greenberg; P Brian Smith
Journal:  J Pediatr       Date:  2017-01-18       Impact factor: 4.406

Review 8.  Bronchopulmonary dysplasia.

Authors:  Bernard Thébaud; Kara N Goss; Matthew Laughon; Jeffrey A Whitsett; Steven H Abman; Robin H Steinhorn; Judy L Aschner; Peter G Davis; Sharon A McGrath-Morrow; Roger F Soll; Alan H Jobe
Journal:  Nat Rev Dis Primers       Date:  2019-11-14       Impact factor: 52.329

Review 9.  Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates.

Authors:  Vibhuti S Shah; Arne Ohlsson; Henry L Halliday; Michael Dunn
Journal:  Cochrane Database Syst Rev       Date:  2017-01-04

10.  Endothelial Extracellular Vesicles in Pulmonary Function and Disease.

Authors:  Eleftheria Letsiou; Natalie Bauer
Journal:  Curr Top Membr       Date:  2018-10-08       Impact factor: 3.049
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.